A bottle of Prasco Laboratories Hydroxychloroquine Sulphate is arranged for a photograph in Queens, New York, April 7, 2020.
Christopher Occhicone | Bloomberg | Getty Images
The World Health Organization announced Wednesday it is dropping hydroxychloroquine, the malaria drug backed by President Donald Trump, from its global study looking at potential treatments for the coronavirus.
The decision to end hydroxychloroquine testing in the Solidarity trial came after data from the trial and another study suggested it would not be beneficial, said Ana Maria Henao Restrepo, a WHO medical officer.
The announcement is likely to further dampen hopes the drug is